Table 1.
Comparison of baseline data between the two groups
| Clinical indicators | Experimental group (n=66) | Control group (n=54) | t/χ2 | P |
|---|---|---|---|---|
| Age | 35.36±15.68 | 37.65±17.98 | 1.564 | 0.324 |
| Gender | 0.987 | 0.416 | ||
| Male | 37 (56.06%) | 29 (53.70%) | ||
| Female | 29 (43.94%) | 25 (46.30%) | ||
| Disease course (years) | 5.03±6.36 | 4.54±4.87 | 1.297 | 0.339 |
| Height | 176.65±5.36 | 178.31±6.23 | 2.006 | 0.268 |
| Weight | 156.62±7.68 | 156.66±8.64 | 1.446 | 0.326 |
| Body mass index | 21.22±1.78 | 22.09±1.09 | 2.098 | 0.3254 |
| Disease type | 0.847 | 0.587 | ||
| High complex anal fistula | 38 (57.58%) | 37 (68.52%) | ||
| High perianal abscess | 28 (42.42%) | 17 (31.48%) | ||
| Diabetes | 38 (57.58%) | 36 (66.7%) | 1.095 | 0.439 |
| Hypertension | 29 (45.31%) | 20 (37.03%) | 1.143 | 0.546 |
| Coronary heart disease | 32 (48.48%) | 20 (37.03%) | 3.876 | 0.098 |
| Chronic Kidney disease | 12 (18.18%) | 9 (16.67%) | 1.766 | 0.657 |